← Leaderboards
William David Nes
Texas Tech University
$2,076,256
Attributed
$2,076,256
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $319.4K · FY2015–19$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$2,076,256 · 3
By mechanism
R33$881,354 · 1
R01$747,830 · 1
R21$447,072 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Active Sites”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$546,695,551
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Albert Lazzarini · California Institute Of Technology$372,427,285
Research focus
Active SitesMethyltransferaseLanosterolErgosterolAnabolismAmebiasisAidsAmoeba GenusAffinity LabelingAmphotericin BCarbonAnalogAnimalsAntifungal AgentsAmino Acid SequenceAcanthamoebaBaseAcanthamoeba KeratitisBinding SitesBiochemicalBiological AvailabilityCandida AlbicansAzolesAdme Study
Grant awards (9)
Discovery of New Anti-amoeba Therapeutics$251,000
R33 · FY2019 · AI · contact PI
Discovery of New Anti-amoeba Therapeutics$319,373
R33 · FY2018 · AI · contact PI
Discovery of New Anti-amoeba Therapeutics$310,981
R33 · FY2017 · AI · contact PI
Discovery of New Anti-amoeba Therapeutics$238,147
R21 · FY2016 · AI · contact PI
Discovery of New Anti-amoeba Therapeutics$208,925
R21 · FY2015 · AI · contact PI
Enzyme Targets-Sterol Synthesis-Opportunistic Pathogens$181,770
R01 · FY2004 · GM
Enzyme Targets-Sterol Synthesis-Opportunistic Pathogens$181,770
R01 · FY2003 · GM
Enzyme Targets-Sterol Synthesis-Opportunistic Pathogens$181,770
R01 · FY2002 · GM
Enzyme Targets-Sterol Synthesis-Opportunistic Pathogens$202,520
R01 · FY2001 · GM